Now showing items 1-2 of 2

    • Roco, Ángela; Nieto, Elena; Suárez, Marcelo; Rojo, Mario; Bertoglia, María Paz; Verón, Gabriel; Tamayo, Francisca; Arredondo, Annabella; Cruz, Daniela; Muñoz, Jessica; Bravo, Gabriela; Salas, Patricio; Mejías, Fanny; Godoy, Gerald; Véliz, Paulo; Quiñones Sepúlveda, Luis (Frontiers Media, 2020)
      Background Vitamin K antagonists (VKA) are used as prophylaxis for thromboembolic events in patients with cardiovascular diseases. The most common VKA are warfarin and acenocoumarol. These drugs have a narrow therapeutic ...
    • Zhou, Wei; Schwarting, Sönke; Illanes, Sergio; Liesz, Arthur; Middelhoff, Moritz; Zorn, Markus; Bendszus, Martin; Heiland, Sabine; Van Ryn, Joanne; Veltkamp, Roland (2011)
      Background and Purpose: Dabigatran-etexilate (DE) recently has been approved for stroke prevention in atrial fibrillation. However, lack of effective antagonists represents a major concern in the event of intracerebral ...